Health policies on dialysis modality selection: a nationwide population cohort study

被引:10
作者
Lin, Yi-Chun [1 ,2 ]
Lin, Yen-Chung [3 ,4 ]
Kao, Chih-Chin [3 ,4 ]
Chen, Hsi-Hsien [3 ,4 ]
Hsu, Chih-Cheng [5 ]
Wu, Mai-Szu [3 ,4 ]
机构
[1] Taipei Vet Gen Hosp, Div Endocrinol & Metab, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan
[3] Taipei Med Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan
[4] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan
[5] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan
来源
BMJ OPEN | 2017年 / 7卷 / 01期
关键词
Accreditations; Health policies; Peritoneal dialysis; Health insurance reimbursement; End Stage Renal Disease; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; PERITONEAL-DIALYSIS; TAIWAN; MORTALITY; IMPACT; HEMODIALYSIS; CARE;
D O I
10.1136/bmjopen-2016-013007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives In Taiwan, peritoneal dialysis (PD) and haemodialysis are fully accessible to patients with end-stage renal disease. However, the usage of PD is considered low in Taiwan. Since 2005, 4 major policies have been implemented by Taiwan's Ministry of Health and Welfare, namely a multidisciplinary predialysis care programme and usage increasing the PD incidence as a key performance indicator (KPI) for hospital accreditation, both of which were implemented in 2006; reimbursement of the glucose-free dialysate, icodextrin that was implemented in 2007; and insurance reimbursement for renting automated PD machines that was implemented in 2008. The aim of this study was to analyse the associations between the PD promotional policies and the actual PD selection rates. Setting We analysed data within the Taiwan Renal Registry Data System from 2006 to 2013, focusing on the PD incidence in relation to the timings of the 4 PD promotional policies; then we stratified the results according to age, sex and the presence of diabetes mellitus. Participants From 2006 to 2013, 115565 patients were enrolled in this study. The mean (SD) age of patients on PD was 54.6 (15.7) years. Results During the time frame in which the 4 PD promotional policies were implemented, the PD incidence increased from 12.8% in 2006 to 15.1% in 2009. The PD incidence started to decline in 2010 (13.8%) when the hospital accreditation policy was repealed. The 3 remaining policies were weakly associated with the PD incidence. The observational analysis determined that the patients' ages, sexes and diabetes mellitus incidence rates were relatively stable from 2006 to 2013. Conclusions Of the 4 health policies intended to promote PD usage, using increasing the PD incidence as a KPI for hospital accreditation had the strongest association with the PD incidence.
引用
收藏
页数:7
相关论文
共 28 条
[1]  
[Anonymous], 2012, ACTA NEPHROLOGICA
[2]  
[Anonymous], JAMA
[3]   Integrated end-stage renal disease care: the role of peritoneal dialysis [J].
Blake, PG .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 :61-66
[4]   The Future of Peritoneal Dialysis in the United States: Optimizing Its Use [J].
Burkart, John .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 :S125-S131
[5]   The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan [J].
Chen, Li-Chia ;
Schafheutle, Ellen I. ;
Noyce, Peter R. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2009, 5 (03) :211-224
[6]   Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study [J].
Chen, Yue-Ren ;
Yang, Yu ;
Wang, Shu-Chuan ;
Chiu, Ping-Fang ;
Chou, Wen-Yu ;
Lin, Ching-Yuang ;
Chang, Jer-Ming ;
Chen, Tzen-Wen ;
Ferng, Shyang-Hwa ;
Lin, Chun-Liang .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (03) :671-682
[7]   Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials [J].
Cho, Yeoungjee ;
Johnson, David W. ;
Badve, Sunil ;
Craig, Jonathan C. ;
Strippoli, Giovanni F. K. ;
Wiggins, Kathryn J. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (07) :1899-1907
[8]   Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalities [J].
Cleemput, Irina ;
De Laet, Chris .
HEALTH POLICY, 2013, 110 (2-3) :172-179
[9]  
Dhanakijcharoen Prateep, 2011, J Med Assoc Thai, V94 Suppl 4, pS153
[10]   The USRDS: What You Need to Know about What It Can and Can't Tell Us about ESRD [J].
Foley, Robert N. ;
Collins, Allan J. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (05) :845-851